ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 157 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 3.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $4,000 | +33.3% | 247 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | -62.5% | 247 | -61.3% | 0.00% | – |
| Q4 2017 | $8,000 | -27.3% | 638 | -26.6% | 0.00% | – |
| Q3 2017 | $11,000 | +57.1% | 869 | +39.0% | 0.00% | – |
| Q2 2017 | $7,000 | -46.2% | 625 | -1.1% | 0.00% | – |
| Q1 2017 | $13,000 | +85.7% | 632 | +81.6% | 0.00% | – |
| Q4 2016 | $7,000 | -75.9% | 348 | -70.4% | 0.00% | – |
| Q2 2016 | $29,000 | -9.4% | 1,175 | -9.7% | 0.00% | – |
| Q1 2016 | $32,000 | -34.7% | 1,301 | -11.5% | 0.00% | – |
| Q4 2015 | $49,000 | +2.1% | 1,470 | -0.4% | 0.00% | – |
| Q3 2015 | $48,000 | – | 1,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |